IDH2 and glioma: Here, we present data for 32 tumors with proven or suspected primary MMR deficiency forming a novel epigenetic group of IDH-mutant gliomas with an astrocytic phenotype and distinct molecular and clinical parameters including an aggressive biological behavior.